Self-administered, non-invasive, transcutaneous viral detector

    公开(公告)号:US12121321B2

    公开(公告)日:2024-10-22

    申请号:US17954026

    申请日:2022-09-27

    Applicant: 123IV, Inc.

    Abstract: A non-invasive, transcutaneous, real-time viral detection device that is configured for self-administration, e.g., at a user's home. In one embodiment, and after positioning the device relative to the human body part (e.g., the user's finger), light sources in the device are activated (excited), and resulting data captured. In particular, a set of Raman spectra are collected from a configured set of emitters and detectors in the device and delivered to a nearby receiver, preferably wirelessly. The receiver filters and de-convolves the Raman spectra producing a data set representative of the constituent elements in the user's tissue of interest. The data set is applied against a statistical classifier, e.g., a neural network that has been trained to recognize and distinguish the absence or presence of viral components, e.g., C-19, or its associated blood-borne acute phase reactants. The classifier outputs an appropriate indicator, preferably in real-time, providing the user with an immediate indication of whether C-19 (or other virus of interest) is present.

    SYSTEM AND METHOD FOR PERFORMING SURGERY WITH REAL-TIME HEALTH PARAMETER MONITORING

    公开(公告)号:US20240315586A1

    公开(公告)日:2024-09-26

    申请号:US18187329

    申请日:2023-03-21

    Inventor: John CRONIN

    Abstract: Methods of using a system for real-time monitoring of blood analytes to reduce the risk of surgical complications. The system includes an apparatus for generating radio frequency scanning data which includes a transmitter for transmitting radio waves below the skin surface of a person and a two-dimensional array of receive antennas for receiving the radio waves, including a portion of the transmitted radio waves that interact with a blood vessel of the person. The wave signal is compared to known standard waveforms, and similar waveforms are input into a machine learning algorithm to determine one or more health parameters of the person. The system then notifies the person and/or health professionals of the person's health status. Two apparatuses are used to collect waveform data for two different analytes. The analyte waveforms are analyzed to determine the patient's analyte levels. The system reports risks associated with at least one analyte level.

    METHOD FOR EVALUATION OF PHOTOPLETHYSMOGRAPHY SIGNAL PULSES

    公开(公告)号:US20240315583A1

    公开(公告)日:2024-09-26

    申请号:US18573153

    申请日:2022-06-20

    Inventor: Flavio Raschella

    CPC classification number: A61B5/02416 A61B5/7242 A61B5/7246 A61B5/7264

    Abstract: The present invention relates to a method (1) of evaluating a detected pulse in a Photoplethysmography. PPG, signal (10) in a PPG signal measurement, the method comprising the steps of (a) receiving the PPG signal comprising a plurality of pulses (20): (b) extracting pulses from the received PPG signal: (c) providing one or more predetermined pulse templates (30): (d) selecting one or more pulse templates (32) out of the provided pulse templates (30): (c) adapting the selected one or more pulse templates to the shape of a first pulse (22) out of the identified pulses (20) in the PPG signal (10); and (f) performing a morphological comparison between the first pulse (22) and each of the adapted one or more pulse templates (34) to provide a quantification of the difference (AD) between the first pulse and the adapted one or more pulse templates.

Patent Agency Ranking